The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2009
Filed:
Aug. 27, 2004
Pamela Ann Albaugh, Carlsbad, CA (US);
Esteban Dominguez-manzanares, Alcobendas, ES;
Jian Eric Hong, Carmel, IN (US);
William Joseph Hornback, Fishers, IN (US);
Delu Jiang, Carmel, IN (US);
Paul Leslie Ornstein, Carmel, IN (US);
Michelle Lee Thompson, Greenwood, IN (US);
Eric George Tromiczak, Carmel, IN (US);
Zhipei Wu, Noblesville, IN (US);
Hamideh Zarrinmayeh, Carmel, IN (US);
Dennis Michael Zimmerman, Zionsville, IN (US);
Ana Maria Castano Mansanet, Alcobendas, ES;
Larry Gene Huffman, Indianapolis, IN (US);
William David Miller, Indianapolis, IN (US);
Pamela Ann Albaugh, Carlsbad, CA (US);
Esteban Dominguez-Manzanares, Alcobendas, ES;
Jian Eric Hong, Carmel, IN (US);
William Joseph Hornback, Fishers, IN (US);
Delu Jiang, Carmel, IN (US);
Paul Leslie Ornstein, Carmel, IN (US);
Michelle Lee Thompson, Greenwood, IN (US);
Eric George Tromiczak, Carmel, IN (US);
Zhipei Wu, Noblesville, IN (US);
Hamideh Zarrinmayeh, Carmel, IN (US);
Dennis Michael Zimmerman, Zionsville, IN (US);
Ana Maria Castano Mansanet, Alcobendas, ES;
Larry Gene Huffman, Indianapolis, IN (US);
William David Miller, Indianapolis, IN (US);
Eli Lilly and Company, Indianapolis, IN (US);
Abstract
The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.